Deutsche Bank’s Thorne Healthtech, Inc. Common Stock THRN Stock Holding History

Deutsche Bank’s Portfolio THRN Stock Details THRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-12,907	Closed	-$132K	–	3806
2023 Q3	$132K	Hold	12,907	–	–	﹤0.01%	3030
2023 Q2	$60.7K	Buy	12,907 +3,479	+37%	+$16K	﹤0.01%	3435
2023 Q1	$43.6K	Buy	9,428 +974	+12%	+$4.29K	﹤0.01%	3578
2022 Q4	$30.7K	Buy	8,454 +94	+1%	+$417	﹤0.01%	3697
2022 Q3	$40K	Sell	8,360 -916	-10%	-$4.6K	﹤0.01%	3651
2022 Q2	$45K	Buy	9,276 +5,637	+155%	+$34.3K	﹤0.01%	3795
2022 Q1	$23K	Sell	3,639 -440	-11%	-$2.37K	﹤0.01%	4039
2021 Q4	$25K	Buy	+4,079	New	+$31.9K	﹤0.01%	4104

Deutsche Bank's THRN Position: Q4 2023 in Review

Deutsche Bank sold out of Thorne Healthtech, Inc. Common Stock (THRN) in Q4 2023, closing a stake of 12,907 shares — an estimated $132K sold.

Deutsche Bank first reported a position in THRN in Q4 2021 and held it in 8 quarters. The position peaked at $132K in Q3 2023. 0 funds tracked by Wall St. Rank hold THRN as of Q4 2023.

Deutsche Bank reported no remaining Thorne Healthtech, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Deutsche Bank sold 12,907 Thorne Healthtech, Inc. Common Stock shares in Q4 2023, an estimated $132K.
Deutsche Bank first reported a position in Thorne Healthtech, Inc. Common Stock in Q4 2021 and held it in 8 quarters.
Deutsche Bank's Thorne Healthtech, Inc. Common Stock position peaked at $132K in Q3 2023.
0 funds tracked by Wall St. Rank held Thorne Healthtech, Inc. Common Stock as of Q4 2023.

Based on Deutsche Bank's 13F filing for Q4 2023, filed 14 Feb 2024.